Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Covid-19 pandemic: knock-on effects for pharma supply chains

Covid-19 originated in China, which is where the clear majority of APIs for drugs are manufactured; China’s lockdown had a knock-on effect on its neighbour India, which relies on those APIs to produce generic drugs. What long-term impact could this have on supply chains and could it push pharma companies to seek to move their API manufacturing back to home soil?


Go Top